rs13204

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_005022.4(PFN1):​c.334C>T​(p.Leu112Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0471 in 1,610,122 control chromosomes in the GnomAD database, including 3,106 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.050 ( 317 hom., cov: 32)
Exomes 𝑓: 0.047 ( 2789 hom. )

Consequence

PFN1
NM_005022.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.0170

Publications

18 publications found
Variant links:
Genes affected
PFN1 (HGNC:8881): (profilin 1) This gene encodes a member of the profilin family of small actin-binding proteins. The encoded protein plays an important role in actin dynamics by regulating actin polymerization in response to extracellular signals. Deletion of this gene is associated with Miller-Dieker syndrome, and the encoded protein may also play a role in Huntington disease. Multiple pseudogenes of this gene are located on chromosome 1. [provided by RefSeq, Jul 2012]
PFN1 Gene-Disease associations (from GenCC):
  • amyotrophic lateral sclerosis type 18
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp
  • amyotrophic lateral sclerosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant 17-4945989-G-A is Benign according to our data. Variant chr17-4945989-G-A is described in ClinVar as Benign. ClinVar VariationId is 259607.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.017 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.191 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PFN1NM_005022.4 linkc.334C>T p.Leu112Leu synonymous_variant Exon 3 of 3 ENST00000225655.6 NP_005013.1 P07737
PFN1NM_001375991.1 linkc.*418C>T 3_prime_UTR_variant Exon 2 of 2 NP_001362920.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PFN1ENST00000225655.6 linkc.334C>T p.Leu112Leu synonymous_variant Exon 3 of 3 1 NM_005022.4 ENSP00000225655.5 P07737
PFN1ENST00000574872.1 linkc.226C>T p.Leu76Leu synonymous_variant Exon 2 of 2 2 ENSP00000465019.1 K7EJ44

Frequencies

GnomAD3 genomes
AF:
0.0502
AC:
7630
AN:
152006
Hom.:
317
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0275
Gnomad AMI
AF:
0.0428
Gnomad AMR
AF:
0.122
Gnomad ASJ
AF:
0.0536
Gnomad EAS
AF:
0.202
Gnomad SAS
AF:
0.0994
Gnomad FIN
AF:
0.0245
Gnomad MID
AF:
0.0538
Gnomad NFE
AF:
0.0366
Gnomad OTH
AF:
0.0556
GnomAD2 exomes
AF:
0.0700
AC:
17602
AN:
251406
AF XY:
0.0680
show subpopulations
Gnomad AFR exome
AF:
0.0290
Gnomad AMR exome
AF:
0.139
Gnomad ASJ exome
AF:
0.0631
Gnomad EAS exome
AF:
0.200
Gnomad FIN exome
AF:
0.0258
Gnomad NFE exome
AF:
0.0366
Gnomad OTH exome
AF:
0.0650
GnomAD4 exome
AF:
0.0468
AC:
68194
AN:
1457998
Hom.:
2789
Cov.:
29
AF XY:
0.0482
AC XY:
35005
AN XY:
725604
show subpopulations
African (AFR)
AF:
0.0255
AC:
852
AN:
33392
American (AMR)
AF:
0.137
AC:
6137
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.0622
AC:
1623
AN:
26110
East Asian (EAS)
AF:
0.220
AC:
8727
AN:
39666
South Asian (SAS)
AF:
0.0958
AC:
8250
AN:
86118
European-Finnish (FIN)
AF:
0.0268
AC:
1430
AN:
53406
Middle Eastern (MID)
AF:
0.0757
AC:
436
AN:
5760
European-Non Finnish (NFE)
AF:
0.0337
AC:
37331
AN:
1108586
Other (OTH)
AF:
0.0566
AC:
3408
AN:
60252
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
2748
5497
8245
10994
13742
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1574
3148
4722
6296
7870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0502
AC:
7631
AN:
152124
Hom.:
317
Cov.:
32
AF XY:
0.0531
AC XY:
3949
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.0275
AC:
1141
AN:
41514
American (AMR)
AF:
0.123
AC:
1875
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.0536
AC:
186
AN:
3468
East Asian (EAS)
AF:
0.202
AC:
1039
AN:
5154
South Asian (SAS)
AF:
0.0985
AC:
474
AN:
4814
European-Finnish (FIN)
AF:
0.0245
AC:
260
AN:
10600
Middle Eastern (MID)
AF:
0.0544
AC:
16
AN:
294
European-Non Finnish (NFE)
AF:
0.0366
AC:
2487
AN:
67984
Other (OTH)
AF:
0.0540
AC:
114
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
342
683
1025
1366
1708
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
96
192
288
384
480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0402
Hom.:
73
Bravo
AF:
0.0569
Asia WGS
AF:
0.126
AC:
437
AN:
3478
EpiCase
AF:
0.0394
EpiControl
AF:
0.0389

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aug 31, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:3
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Amyotrophic lateral sclerosis type 18 Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.47
CADD
Benign
12
DANN
Benign
0.87
PhyloP100
-0.017
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13204; hg19: chr17-4849284; COSMIC: COSV52591045; COSMIC: COSV52591045; API